MEG3 and lung cancer: The overexpression of MEG3 also enhanced cisplatin sensitivity in cisplatin-resistant lung cancer cells by regulating the miR-21-5p/SOX7 axis, in vitro and in vivo models, impeding cell proliferation, and inducing apoptosis (Wang et al., 2017).